SAN FRANCISCO -- Including encorafenib (Braftovi) and cetuximab (Erbitux) in the first-line treatment of BRAF V600E-mutated ...

Many Americans aren't getting enough fiber, while colorectal cancer rates are increasing in younger adults. Is fibermaxxing ...

Greater background mucosal inflammation was associated with poorer survival outcomes in patients with ulcerative colitis who ...

GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results ...

According to a 2025 survey conducted by the Prevent Cancer Foundation, only 51% of U.S. adults 21 and older say they have had ...

Experts point to a combination of environmental factors and lifestyle factors, such as diets high in red meat and ...

But new research may have found the key to answering the mysterious increase in colorectal cancer cases in young people — and ...

# “While aspirin has been studied for colorectal cancer prevention, its modest benefit and bleeding risks limit its use.

Company closed $22M financing to support randomized Phase 2b trial; IND cleared and study initiated; Interim results anticipated in late 2026; topline data expected in H2/2027 ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for colorectal cancer screening (CRC) is now covered for active-duty service members and ...

Opportunities in the colorectal cancer drugs market include growth in targeted therapy and immunotherapy, advancements in ...